IMPAX LABS FDA Approval ANDA 085113

ANDA 085113

IMPAX LABS

FDA Drug Application

Application #085113

Application Sponsors

ANDA 085113IMPAX LABS

Marketing Status

Discontinued001

Application Products

001CAPSULE;ORAL10MG0CHLORDIAZEPOXIDE HYDROCHLORIDECHLORDIAZEPOXIDE HYDROCHLORIDE

FDA Submissions

ORIG1AP1977-12-12
LABELING; LabelingSUPPL7AP1989-01-11
LABELING; LabelingSUPPL8AP1989-10-24
LABELING; LabelingSUPPL9AP1990-07-09
LABELING; LabelingSUPPL10AP1991-09-17
LABELING; LabelingSUPPL11AP1992-09-17

Submissions Property Types

ORIG1Null0
SUPPL7Null0
SUPPL8Null0
SUPPL9Null0
SUPPL10Null0
SUPPL11Null0

CDER Filings

IMPAX LABS
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 85113
            [companyName] => IMPAX LABS
            [docInserts] => ["",""]
            [products] => [{"drugName":"CHLORDIAZEPOXIDE HYDROCHLORIDE","activeIngredients":"CHLORDIAZEPOXIDE HYDROCHLORIDE","strength":"10MG","dosageForm":"CAPSULE;ORAL","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"CHLORDIAZEPOXIDE HYDROCHLORIDE","submission":"CHLORDIAZEPOXIDE HYDROCHLORIDE","actionType":"10MG","submissionClassification":"CAPSULE;ORAL","reviewPriority":"Discontinued","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 1969-12-31
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.